This site is intended for Healthcare Professionals only.

UK scientists to track mutations in coronavirus to map spread

Date:

Share post:

UK scientists are to track the spread of the new coronavirus and watch for emerging mutations by using gene sequencing to analyse the strains causing thousands of COVID-19 infections across the country, Britain said on Monday.

Researchers will collect data from samples from infected patients in England, Wales, Scotland and Northern Ireland, the government said in a statement.

At least 281 Britons have died from COVID-19, the disease caused by the new coronavirus that has spread around the world in a pandemic.

“This virus is one of the biggest threats our nation has faced in recent times, and crucial to helping us fight it is understanding how it is spreading,” said Sharon Peacock, director of Public Health England’s (PHE) national infection service.

Working in teams across Britain, scientists will map out and analyse the full genetic codes of the COVID-19 samples.

“Genomic sequencing will help us understand COVID-19 and its spread. It can also help guide treatments in the future and see the impact of interventions,” Patrick Vallance, the government’s chief scientific adviser, said in the statement.

In epidemics, genome sequencing can help scientists monitor small changes in the virus at a national or international scale to understand how it is spreading and whether different strains are emerging.

“Right now, the important questions we can help answer with sequencing are to help understand the role of international importations into the UK,” said Nick Loman, a professor of microbial genomics and bioinformatics at Birmingham University.

The £20 million project, called the COVID-19 Genomics UK Consortium, will be co-led by the Wellcome Sanger Institute, which specialises in genetic research, PHE and other public health agencies, as well as the NHS and several academic institutions.

“All viruses accumulate mutations over time, some faster than others,” said Paul Klenerman, a professor at Oxford University who will be involved in the work. “For Covid-19, this has only just begun – but this emerging variation can be tracked in detail.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

DHSC also publishes a new 10-year strategic plan to expand and improve the drug and alcohol workforce The...

New NHS patient choice scheme offers 5 options, but nursing shortages persist

Royal College of Nursing CE urges caution amidst new NHS patient choice pilot scheme rollout "Patients deserve choice, but...

Prof Ryan Donnelly awarded prestigious RPS Harrison Memorial Medal 2024

RPS HMM winner Professor Donnelly's work has secured £30M+ funding through his pioneering work in developing advanced polymeric...

Pharmacies forced to subsidise NHS medicines: NPA hands £108m invoice to DHSC

The NPA calls for a new deal that reverses “historical funding cuts and gives the sector the respect...